COVID-19 Severity Does Not Differ for Patients With Skin Conditions
WEDNESDAY, Dec. 15, 2021 -- For patients with psoriasis, vitiligo, atopic dermatitis (AD), and chronic urticaria (CU), COVID-19 severity does not differ, but treatment of COVID-19 may affect the course of skin disease, according to a letter to the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: COVID-19 | Dermatitis | Dermatology | Hives | Pharmaceuticals | Psoriasis | Skin | Vitiligo